Nicoccino Holding AB Logo

Nicoccino Holding AB

Develops and markets a patented, dissolvable, tobacco-free nicotine strip.

NICO | ST

Overview

Corporate Details

ISIN(s):
SE0005506185
LEI:
549300C2GLW07PG6ND62
Country:
Sweden
Address:
Gillinge 55, 186 91 Vallentuna

Description

Nicoccino Holding AB develops, manufactures, and markets innovative, tobacco-free nicotine products for adult consumers. The company's core product is a patented, dissolvable nicotine strip. This thin film is placed under the upper lip, where it delivers pharmaceutical-grade nicotine through the oral mucosa within seconds and dissolves completely in a few minutes. This delivery system provides a discreet, convenient, and waste-free alternative to traditional nicotine products, leaving no residue. The strips are clinically tested for safety and efficacy, are made from food-grade ingredients, and have a two-year shelf life.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Nicoccino Holding AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Nicoccino Holding AB

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Nicoccino Holding AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Cogent Biosciences, Inc. Logo
A clinical-stage biotech company developing precision therapies for genetic diseases.
United States of America
COGT
Coherus Oncology, Inc. Logo
Biopharmaceutical company developing and commercializing immuno-oncology therapies.
United States of America
CHRS
COLLEGIUM PHARMACEUTICAL, INC Logo
A biopharmaceutical company developing abuse-deterrent pain management medications.
United States of America
COLL
CollPlant Biotechnologies Ltd Logo
Develops plant-derived collagen for 3D bioprinting of tissues and organs.
United States of America
CLGN
COMPASS Pathways plc Logo
Develops psilocybin treatments for difficult-to-treat mental health conditions.
United States of America
CMPS
Compass Therapeutics, Inc. Logo
Clinical-stage biopharma developing antibody-based therapeutics for oncology.
United States of America
CMPX
Connect Biopharma Holdings Ltd Logo
A clinical-stage biopharma developing therapies for T cell-driven inflammatory diseases.
United States of America
CNTB
Context Therapeutics Inc. Logo
Clinical-stage biopharma developing T cell engaging bispecific antibodies for solid tumors.
United States of America
CNTX
Contineum Therapeutics, Inc. Logo
Clinical-stage biopharma developing oral small molecule therapies for NI&I conditions.
United States of America
CTNM
Corbus Pharmaceuticals Holdings, Inc. Logo
Clinical-stage biopharma developing targeted therapies for oncology and obesity.
United States of America
CRBP

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.